Unlocking Access: How Primary Care Can Transform Sickle Cell Anemia Treatment
"Understanding the barriers and pathways to better care for those living with sickle cell anemia."
Sickle cell anemia (SCA), a genetic blood disorder, disproportionately affects specific populations, particularly those of African descent. While significant advancements have been made in understanding and treating SCA, accessing adequate healthcare remains a major challenge for many individuals. This article delves into the current state of primary care for people with SCA, highlighting the barriers to accessing care and exploring potential strategies to improve health outcomes.
The journey of a person with SCA is often marked by frequent hospital visits and the need for specialized care, often at blood centers. However, primary care can play a pivotal role in managing the condition, offering preventive care, and coordinating overall health. Despite this, access to primary care for SCA patients is often limited, creating significant gaps in their healthcare experience.
This article draws on research to explore the perspectives of healthcare providers, especially community health agents, in understanding the challenges in SCA care. By examining the current system's limitations and potential solutions, we aim to shed light on how to improve access and quality of life for individuals living with SCA.
Measuring Sickle Cell Disease
The CDC provides data and statistics on sickle cell disease prevalence, complications, and related impacts. Its Sickle Cell Data Collection program tracks long-term trends in diagnosis, treatment, and healthcare access for people with SCD in the United States. Together, these resources show why ongoing population-level surveillance is important for evaluating both disease burden and access to care.
Guidelines and Gaps
UCSF’s Sickle Cell Center of Excellence maintains standard-of-care guidelines based on research and literature review. The NHLBI evidence-based guidelines are intended to help providers manage SCD, but one review reports that provider adoption has not been optimal. Primary care management is multifocal, requiring basic disease knowledge alongside specialized care, while the National Alliance of Sickle Cell Centers has proposed additional standards for preventive care and treatment.
A Century of Progress
The history of sickle cell disease spans more than a century, from its first description in 1910 to gene-therapy breakthroughs reported in 2023. NHLBI’s timeline explains that stiff, sticky sickled cells can clump, block blood flow, and cause episodes of extreme pain known as crises. Historical accounts also describe how 20th-century molecular findings transformed understanding of sickle cell anemia as a genetic disease.
The Current Landscape: Challenges in Primary Care for Sickle Cell Anemia
The research reveals several key challenges in primary care for SCA patients. One significant issue is the limited access to primary care services, with patients often relying on emergency care and blood centers. Barriers like a lack of knowledge among primary care providers regarding SCA, and the families' preference for specialized care over general primary care contribute to this problem.
- Limited Access to Primary Care: Patients often bypass primary care, going straight to emergency services.
- Knowledge Gaps: Lack of awareness among healthcare providers about SCA management and specific needs.
- Inadequate Prioritization: Urgent cases may not receive timely attention, and routine follow-up care may be lacking.
- Ineffective Home Visits: Home visits are not always systematically planned, and key aspects of care may be overlooked.
Research and Primary Care
A recent review describes a treatment divide: cutting-edge technologies have supported new treatments in developed countries, while medical management in settings where SCD is more prevalent still relies on hydroxyurea, blood transfusions, and analgesics. Another 2026 review emphasizes that primary healthcare providers are important for facilitating adherence to care practices and delivering comprehensive services through culturally responsive care. CDC material further notes that children with SCD have complex health needs that benefit from ongoing specialized healthcare.
Why Primary Care Still Matters
SCD causes substantial morbidity, including multiorgan damage, chronic anemia, and debilitating pain crises. The Cleveland Clinic review argues that primary care physicians play a key role in the medical-home model for adults with SCD, including health maintenance. The Foundation for Sickle Cell Disease Research’s 2025 practice update similarly rejects the idea that primary care has only a limited role, describing a medical home as a partnership among the patient, family, primary care physician, and other medical staff.
Integrated Adult Care
Sickle cell disease affects more than 100,000 Americans, mostly people of Black or African ancestry, according to the report on integrated primary care. Comprehensive care models have traditionally focused on pediatric and inpatient settings. The same source notes that multidisciplinary models for adults, particularly those including primary care physicians, remain relatively uncommon despite a long-recognized need.
Charting a Course for Improved Care
Improving primary care for individuals with sickle cell anemia requires a multifaceted approach. This includes educating healthcare providers about the disease and its management, establishing clear protocols for patient care, and improving access to essential services. By focusing on these areas, healthcare systems can significantly improve the lives of those affected by this chronic condition.
Primary Care as the Connector
The 2026 review describes the primary healthcare system as essential for helping people with SCD adhere to care practices. It also reports that effective disease management is often compromised even as primary healthcare systems are strengthened. These findings support a role for primary healthcare providers in coordinating comprehensive, culturally responsive SCD care rather than treating primary care as separate from specialist services.
Emerging Treatments
Front Line Genomics reports that multiple new-treatment developments for SCD have emerged in recent months and frames the field around what may come next. Penn Medicine’s March 2026 physician interviews likewise review current and future therapies for sickle cell anemia with hematologists Nadia Dawn Ali and Scott Alan Peslak. Together, these sources suggest a rapidly changing treatment landscape, although the snippets do not establish which emerging approaches will become standard care.
Access Beyond Treatment
Primary care transformation may depend on more than clinical protocols because access to SCD care can also be shaped by continuity, coordination, resources, and the ability of health systems to connect patients with appropriate services. These challenges are likely to be especially important when care must span primary care, specialty treatment, prevention, and acute complications. A broader systems approach should therefore be considered alongside advances in therapies.
Continuity and Connection
Adults with SCD can experience fragmented access to primary and preventive care, which may contribute to poor adherence to general and SCD-specific clinical practice guidelines. One implemented model embedded a board-certified internist or pediatric primary care provider as a full member of an adult SCD care team. A separate case study emphasizes early infancy diagnosis, immediate establishment with specialists and general pediatric care, and continuity of care for vulnerable children.